Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series ; volume:15 ; number:1 ; day:19 ; month:3 ; year:2015 ; pages:1-7 ; date:12.2015
BMC cancer ; 15, Heft 1 (19.3.2015), 1-7, 12.2015
- Creator
-
Yoo, Kwai Han
Kim, Hyo Song
Lee, Su Jin
Park, Se Hoon
Kim, Sung Joo
Kim, Soo Hee
La Choi, Yoon
Shin, Kyoo-Ho
Cho, Yong Jin
Lee, Jeeyun
Rha, Sun Young
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1160-x
- URN
-
urn:nbn:de:101:1-2021082107142747591542
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yoo, Kwai Han
- Kim, Hyo Song
- Lee, Su Jin
- Park, Se Hoon
- Kim, Sung Joo
- Kim, Soo Hee
- La Choi, Yoon
- Shin, Kyoo-Ho
- Cho, Yong Jin
- Lee, Jeeyun
- Rha, Sun Young
- SpringerLink (Online service)
Other Objects (12)
Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem